Regulated Information Reference Documents & Financial ReportsLiquidity ContractsNumber of Shares & Voting RightsOfferings Related Documents 2020 16th September 2020 H1 2020 Interim Financial Report 10th July 2020 Amendment N° 1 to URD 2019 (only in French) 10th July 2020 Security note (only in French) 19th June 2020 Universal Registration Document (only in French) 9th April 2020 2019 Annual Financial Report 10th February 2020 Universal Registration Document (only in French) 2019 25th September 2019 H1 2019 Interim Financial Report 6th May 2019 2018 Registration Document including the Annual Financial Report 2018 27th September 2018 H1 2018 Interim Financial Report 16th April 2018 2017 Registration Document including the Annual Financial Report 9th April 2018 2017 IFRS Financial Report 2017 26th September 2017 Interim Financial Report for the six months ended June 30, 2017 2021 15th January 2021 Half-yearly review of the liquidity contract with Kepler Cheuvreux 2020 12th August 2020 Half-yearly review of the liquidity contract with Kepler Cheuvreux 10th August 2020 Description of the share buyback program & resumption of the liquidity contract 14th January 2020 Half-yearly review of the liquidity contract with Kepler Cheuvreux 2019 9th July 2019 Half-yearly review of the liquidity contract with Kepler Cheuvreux 29th January 2019 Half-yearly review of the liquidity contract with Kepler Cheuvreux 2018 9th July 2018 Half-yearly review of the liquidity contract with Kepler Cheuvreux 29th May 2018 2018-2019 Share buyback programme 1st February 2018 Half yearly review and termination of liquidity contract with Oddo BHF 2017 19th July 2017 Half-yearly review of the liquidity contract with Oddo & Cie (only in French) 1st June 2017 Description of the share buyback program & Renewal of the liquidity contract 10th May 2017 Additional information regarding the liquidity contract with Oddo & Cie 2020 30th November 2020 Total Voting Rights and Share – November 30th, 2020 9th November 2020 Total Voting Rights and Share – October 31st, 2020 13th October 2020 Total Voting Rights and Share – September 30th, 2020 10th September 2020 Total Voting Rights and Share – August 31st, 2020 12th May 2020 Total Voting Rights and Shares – April 30th, 2020 7th April 2020 Total Voting Rights and Shars – March 31th, 2020 4th March 2020 Total Voting Right and Shares – February 29th, 2020 14th January 2020 Total Voting Rights and Shares – December 31th, 2019 2019 13th December 2019 Total Voting Rights and Shares – November 30th, 2019 8th October 2019 Total Voting Rights and Shares – September 30th, 2019 5th September 2019 Total Voting Rights and Shares – August 31th, 2019 18th August 2019 Total Voting Rights and Shares – July 31th, 2019 2020 10th February 2020 Securities Note – n° 20-034 (only in French) 2018 16th April 2018 2017 Registration Document including the Annual Financial Report 2017 17th May 2017 2016 Registration Document including the Annual Financial Report 17th March 2017 Confirmed success of IPO and over-allotment option partially exercised 2nd February 2017 Launch of Inventiva’s initial public offering on the regulated market of Euronext Paris 13th January 2017 Update filed to Inventiva’s document de base with a view to its initial public offering 12th January 2017 Updated Document de Base (Only in French) 2nd January 2017 Note d’Opération – no.17-048 (Only in French) 2016 11th July 2016 Registration of Inventiva’s IPO document de base 8th July 2016 Document de Base (Only in french) Investor Contacts Inventiva 50 rue de Dijon 21121 Daix, France Email: finance@inventivapharma.com Tel: +33 (0)3 80 44 75 00 Patti Bank Managing Director ICR Westwicke Patti.Bank@westwicke.com D 415-513-1284 San Francisco, CA www.westwicke.com